Healthcare (Ottawa)
This is Queen Street Analytics' weekly digest of regulatory developments, legislative discussions and other government-related news coming out of Ottawa and the provincial governments.
This newsletter channel is subscribed to by many healthcare providers, doctors, physicians, clinicians, pharmacies and pharmacists, dental care providers, oral care providers, naturopaths, and old-age care providers.
Once a week, we break down the most important updates in this space in under five minutes.
Lobbying Landscapes in Healthcare (October, 2025)
Pfizer; Johnson & Johnson; Merck; AstraZeneca; GSK; Sanofi
QSA's Week in Healthcare (#42, 2025)
Federal report shows drug plan spending climbed $3.4B on high-cost drugs; Parliament committees progress bills on alcohol warning labels and sickle cell disease; Black Canadians’ mental health fund announced; Auditor General calls for improvements in First Nations health programs; Substance use c...
QSA's Week in Healthcare (#41, 2025)
QSA's Week in Healthcare (#40, 2025)
Federal-provincial health ministers to meet in Calgary; CIHR funds breast cancer research; Senate reviews sickle cell and alcohol labelling bills; US orders AI push for pediatric cancer; EPA reconsiders CTC workplace rule.
QSA's Week in Healthcare (#39, 2025)
QSA's Week in Healthcare (#38, 2025)
Federal investment in pandemic preparedness research; Senate committee advances Bill S-228 on sterilization and informed consent; StatsCan releases updated births and population data; Health Canada launches drug labelling consultation; US federal section: no major healthcare developments reported.